Select Recent Tisch Cancer Institute Clinical Faculty and Fellow Publications
Select Recent Tisch Cancer Institute Clinical Faculty and Fellow Publications
2015-2017
Urological cancer: Is docetaxel the 'black widow' of mCRPC drugs?
Liaw BC, Oh WK.
Nat Rev Clin Oncol. 2015 Jun;12(6):316-8. doi: 10.1038/nrclinonc.2015.79. Epub 2015 Apr 28.
Systemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: from intermittent androgen deprivation therapy to chemotherapy.
Liaw BC, Shevach J, Oh WK.
Curr Urol Rep. 2015 Mar;16(3):13. doi: 10.1007/s11934-015-0486-x.
Muscle invasive bladder cancer: closing the gap between practice and evidence.
Tsao CK,Liaw BC, Oh WK, Galsky MD.
Minerva Urol Nefrol. 2015 Mar;67(1):65-73. Epub 2014 Nov 26
Changes in the Trend of Alcohol-Related Cancers: Perspectives on Statistical Trends.
Malhotra J, Praud D, Boffetta P.
Chem Res Toxicol. 2015 Aug 13.
Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
Malhotra J, Mhango G, Gomez JE, Smith C, Galsky MD, Strauss GM, Wisnivesky JP.
Ann Oncol. 2015 Apr;26(4):768-73. doi: 10.1093/annonc/mdv008. Epub 2015 Jan 18.
Effect of occupational exposures on lung cancer susceptibility: a study of gene-environment interaction analysis.
Malhotra J, Sartori S, Brennan P, Zaridze D, Szeszenia-Dabrowska N, Świątkowska B, Rudnai P, Lissowska J, Fabianova E, Mates D, Bencko V, Gaborieau V, Stücker I, Foretova L, Janout V, Boffetta P.
Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):570-9. doi: 10.1158/1055-9965.EPI-14-1143-T. Epub 2015 Jan 12.
Demographic factors and hospital size predict patient satisfaction variance-implications for hospital value-based purchasing.
McFarland DC, Ornstein KA, Holcombe RF.
J Hosp Med. 2015 Aug;10(8):503-9. doi: 10.1002/jhm.2371. Epub 2015 May 4.
Inpatient Hematology-Oncology Rotation Is Associated With a Decreased Interest in Pursuing an Oncology Career Among Internal Medicine Residents.
McFarland DC, Holland J, Holcombe RF.
J Oncol Pract. 2015 Jul;11(4):289-95. doi: 10.1200/JOP.2015.003798. Epub 2015 Jun 9.
The EPIC study: a lesson to learn.
Auerswald G, Kurnik K,Aledort LM, Chehadeh H, Loew-Baselli A, Steinitz K, Reininger AJ; EPIC clinical study group.
Haemophilia. 2015 Apr 23. doi: 10.1111/hae.12
Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption.
Holcombe RF, Martinez M, Planutis K, Planutiene M.
Nutr J. 2015 Jun 19;14:62. doi: 10.1186/s12937-015-0050-z.
Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma.
Barley K, Tindle S, Bagiella E,Jagannath S, Chari A.
Clin Lymphoma Myeloma Leuk. 2015 Sep;15(9):541-5. doi: 10.1016/j.clml.2015.05.004. Epub 2015 Jun 6
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.
Adomako A, Calvo V, Biran N, Osman K, Chari A, Paton JC, Paton AW, Moore K, Schewe DM, Aguirre-Ghiso JA.
BMC Cancer. 2015 May 30;15:444. doi: 10.1186/s12885-015-1460-1.
Diagnostic utility of measuring free light chains in the cerebrospinal fluid of patients with multiple myeloma.
Marron TU, Ramanathan L, Chari A.
Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e127-31. doi: 10.1016/j.clml.2015.02.028. Epub 2015 Mar 5.
Outcome of patients with multiple myeloma and hypotension during high-dose chemotherapy.
Biran N, Sehgal P, Sahni G, Doucette J, Chari A.
Am J Hematol. 2015 Jun;90(6):E125-7. doi: 10.1002/ajh.23991. Epub 2015 Apr 29
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis.
Keyzner A, Han S, Shapiro S, Moshier E, Schorr E, Petersen B, Najfeld V, Kremyanskaya M, Isola L, Hoffman R, Mascarenhas J. Biol Blood Marrow Transplant. 2016 Dec;22(12):2180-2186. doi: 10.1016/j.bbmt.2016.08.029. Epub 2016 Sep 3.
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL.
J Immunother Cancer. 2016 Dec 20;4:92. doi: 10.1186/s40425-016-0198-x. eCollection 2016.
Prostate cancer characteristics in the World Trade Center cohort, 2002-2013.
Hashim D, Boffetta P, Galsky M, Oh W, Lucchini R, Crane M, Luft B, Moline J, Udasin I, Harrison D, Taioli E.
Eur J Cancer Prev. 2016 Nov 24.
Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan.
Simpson WL Jr, Lee KM, Sosa N, Cooper N, Scigliano E, Brody JD, Doucette JT, Kostakoglu L.
Leuk Lymphoma. 2016 May;57(5):1083-93. doi: 10.3109/10428194.2015.1089437. Epub 2015 Nov 16.
Three-dimensional printing for preoperative planning of renal artery aneurysm surgery.
Lin JC, Myers E. J Vasc Surg. 2016 Sep;64(3):810. doi: 10.1016/j.jvs.2015.12.061.
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
Shaffer BC, Ahn KW, Hu ZH, Nishihori T, Malone AK, Valcárcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble R, Rizzieri DA, Cahn JY, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W.
J Clin Oncol. 2016 Jun 1;34(16):1864-71. doi: 10.1200/JCO.2015.65.0515. Epub 2016 Apr 4.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.
Chaudhury S, Sparapani R, Hu ZH, Nishihori T, Abdel-Azim H, Malone A, Olsson R, Hamadani M, Daly A, Bacher U, Wirk BM, Kamble RT, Gale RP, Wood WA, Hale G, Wiernik PH, Hashmi SK, Marks D, Ustun C, Munker R, Savani BN, Alyea E, Popat U, Sobecks R, Kalaycio M, Maziarz R, Hijiya N, Saber W.
Biol Blood Marrow Transplant. 2016 Jun;22(6):1056-64. doi: 10.1016/j.bbmt.2016.02.015. Epub 2016 Mar 8.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Jimeno A, Posner MR, Wirth LJ, Saba NF, Cohen RB, Popa EC, Argiris A, Grossmann KF, Sukari A, Wilson D, Zhang X, Sun J, Glasser C, Attie KM, Sherman ML, Pandya SS, Weiss J.
Cancer. 2016 Dec 1;122(23):3641-3649. doi: 10.1002/cncr.30317. Epub 2016 Sep 20.
Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus.
Sokol KA, Veluswamy RR, Zimmerman BS, Tummalapalli SL, Troy K.
Am J Hematol. 2017 Mar;92(3):322. doi: 10.1002/ajh.24547. Epub 2016 Oct 14. No abstract available.
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.
Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL.
Lancet Haematol. 2017 Sep;4(9):e431-e442. doi: 10.1016/S2352-3026(17)30140-0. Epub 2017 Aug 17
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C.
Biol Blood Marrow Transplant. 2017 Aug;23(8):1327-1334. doi: 10.1016/j.bbmt.2017.04.017. Epub 2017 Apr 28.
Serum Iron Protects from Renal Postischemic Injury.
Vaugier C, Amano MT, Chemouny JM, Dussiot M, Berrou C, Matignon M, Ben Mkaddem S, Wang PHM, Fricot A, Maciel TT, Grapton D, Mathieu JRR, Beaumont C, Peraldi MN, Peyssonnaux C, Mesnard L, Daugas E, Vrtovsnik F, Monteiro RC, Hermine O, Ginzburg YZ, Benhamou M, Camara NOS, Flamant M, Moura IC.
J Am Soc Nephrol. 2017 Aug 7. pii: ASN.2016080926. doi: 10.1681/ASN.2016080926.
Immunoassay for human serum erythroferrone.
Ganz T, Jung G, Naeim A, Ginzburg Y, Pakbaz Z, Walter PB, Kautz L, Nemeth E.
Blood. 2017 Jul 24. pii: blood-2017-04-777987. doi: 10.1182/blood-2017-04-777987
Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm.
Aledort LM, Singleton TC, Ulsh PJ.
J Pediatr Hematol Oncol. 2017 Jul 21. doi: 10.1097/MPH.0000000000000917.
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
Pozo E, Castellano JM, Kanwar A, Deochand R, Castillo-Martin M, Pazos-López P, González-Lengua C, Osman K, Cham M, Cordon-Cardo C, Narula J, Fuster V, Sanz J.
J Card Fail. 2017 Aug 8. pii: S1071-9164(17)31120-X. doi: 10.1016/j.cardfail.2017.08.445.
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab.
Friedlander P, Wassmann K, Christenfeld AM, Fisher D, Kyi C, Kirkwood JM, Bhardwaj N, Oh WK.
J Immunother Cancer. 2017 Aug 15;5:67. doi: 10.1186/s40425-017-0272-z. eCollection 2017.
Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications.
Tsao CK, Liaw B, He C, Galsky MD, Sfakianos J, Oh WK.
Ther Adv Med Oncol. 2017 Apr;9(4):287-298. doi: 10.1177/1758834016687261. Epub 2017 Feb 14. Review.
Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting.
Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS.
Clin Genitourin Cancer. 2017 Jun 19. pii: S1558-7673(17)30170-2. doi: 10.1016/j.clgc.2017.06.004.
The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
Dave E, Ozbek U, Gupta V, Genden E, Miles B, Teng M, Posner M, Misiukiewicz K, Bakst RL.
PLoS One. 2017 Jul 21;12(7):e0181108. doi: 10.1371/journal.pone.0181108. eCollection 2017.
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
Levis BE, Binkley PF, Shapiro CL.
Lancet Oncol. 2017 Aug;18(8):e445-e456. doi: 10.1016/S1470-2045(17)30535-1. Epub 2017 Jul 26. Review
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial.
Adelson K, Ramaswamy B, Sparano JA, Christos PJ, Wright JJ, Raptis G, Han G, Villalona-Calero M, Ma CX, Hershman D, Baar J, Klein P, Cigler T, Budd GT, Novik Y, Tan AR, Tannenbaum S, Goel A, Levine E, Shapiro CL, Andreopoulou E, Naughton M, Kalinsky K, Waxman S, Germain D.
Speaking Up: How Patient and Physician Voices Shaped a Trial to Improve Goals-of-Care Discussions.
Solomon R, Smith C, Kallio J, Fenollosa A, Benerofe B, Jones L, Adelson K, Gonsky JP, Messner C, Bickell NA.
Patient. 2017 Aug;10(4):489-501. doi: 10.1007/s40271-017-0226-z.
1